Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 5.56 USD 1.65% Market Closed
Market Cap: 18.8m USD

Wall Street
Price Targets

EKSO Price Targets Summary
Ekso Bionics Holdings Inc

Wall Street analysts forecast EKSO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EKSO is 7.91 USD with a low forecast of 6.06 USD and a high forecast of 9.98 USD.

Lowest
Price Target
6.06 USD
9% Upside
Average
Price Target
7.91 USD
42% Upside
Highest
Price Target
9.98 USD
79% Upside
Ekso Bionics Holdings Inc Competitors:
Price Targets
BIOBV
Biohit Oyj
8% Upside
SOON
Sonova Holding AG
9% Upside
NVCR
Novocure Ltd
88% Upside
TLT
Theralase Technologies Inc
346% Upside
OPTOMED
Optomed Oyj
30% Upside
041830
InBody Co Ltd
16% Upside
SNWV
SANUWAVE Health Inc
81% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
10% Upside

Revenue
Forecast

Revenue Estimate
Ekso Bionics Holdings Inc

For the last 10 years the compound annual growth rate for Ekso Bionics Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is 19%.

13%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ekso Bionics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Ekso Bionics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EKSO's stock price target?
Price Target
7.91 USD

According to Wall Street analysts, the average 1-year price target for EKSO is 7.91 USD with a low forecast of 6.06 USD and a high forecast of 9.98 USD.

What is Ekso Bionics Holdings Inc's Revenue forecast?
Projected CAGR
19%

For the last 10 years the compound annual growth rate for Ekso Bionics Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is 19%.

Back to Top